Anuh Pharma Ltd
ANUHPHRAnuh Pharma Ltd
ANUHPHRPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
17.54 | 3.48 | 1.24% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.22 | 6.55 | 0.48% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Anuh Pharma Limited is engaged in the manufacturing of pharmaceuticals, medicinal, chemical and botanical products. The Company manufactures active pharmaceutical ingredients (APIs). It also sells bulk drugs and chemicals.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 329.74 | 213.73 | 245.47 | 325.36 | 311.17 | 442.50 | 491.85 | 533.60 | 659.10 | 635.78 | ||||||||||
Raw Materials | 251.07 | 148.76 | 184.07 | 249.16 | 243.67 | 327.49 | 382.54 | 388.00 | 501.90 | 551.69 | ||||||||||
Power & Fuel Cost | 3.48 | 3.07 | 4.09 | 4.79 | 6.31 | 8.66 | 8.80 | 11.02 | 12.37 | |||||||||||
Employee Cost | 6.58 | 7.22 | 8.90 | 10.14 | 13.36 | 14.29 | 15.10 | 17.15 | 19.39 | |||||||||||
Selling & Administrative Expenses | 10.99 | 7.45 | 8.53 | 9.98 | 8.90 | 11.17 | 12.07 | 13.28 | 15.50 | |||||||||||
Operating & Other expenses | 16.55 | 16.96 | 14.18 | 16.63 | 11.48 | 25.23 | 20.67 | 46.23 | 22.09 | |||||||||||
EBITDA | 41.07 | 30.27 | 25.70 | 34.66 | 27.45 | 55.66 | 52.67 | 57.92 | 87.85 | 84.09 | ||||||||||
Depreciation/Amortization | 2.26 | 1.97 | 1.83 | 1.66 | 7.03 | 15.08 | 11.96 | 9.70 | 8.58 | 8.46 | ||||||||||
PBIT | 38.81 | 28.30 | 23.87 | 33.00 | 20.42 | 40.58 | 40.71 | 48.22 | 79.27 | 75.63 | ||||||||||
Interest & Other Items | 0.86 | 0.72 | 0.45 | 0.60 | 1.26 | 2.03 | 1.58 | 0.75 | 0.96 | 0.47 | ||||||||||
PBT | 37.95 | 27.58 | 23.42 | 32.40 | 19.16 | 38.55 | 39.13 | 47.47 | 78.31 | 75.16 | ||||||||||
Taxes & Other Items | 12.13 | 7.54 | 6.90 | 9.04 | 4.85 | 10.12 | 8.56 | 11.29 | 18.25 | 17.35 | ||||||||||
Net Income | 25.82 | 20.04 | 16.52 | 23.36 | 14.31 | 28.43 | 30.57 | 36.18 | 60.06 | 57.81 | ||||||||||
EPS | 5.15 | 4.00 | 3.30 | 4.66 | 2.86 | 5.67 | 6.10 | 7.22 | 11.99 | 11.54 | ||||||||||
DPS | 1.25 | 1.25 | 1.38 | 1.38 | 1.38 | 1.50 | 1.75 | 2.00 | 2.50 | 2.00 | ||||||||||
Payout ratio | 0.24 | 0.31 | 0.42 | 0.29 | 0.48 | 0.26 | 0.29 | 0.28 | 0.21 | 0.17 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Anuh Pharma Ltd | 16.89 | 3.48 | 1.24% |
Sun Pharmaceutical Industries Ltd | 47.86 | 6.83 | 0.71% |
Cipla Ltd | 31.81 | 4.89 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.97 | 17.15 | 0.81% |
Price Comparison
Compare ANUHPHR with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Increasing Dividends
ANUHPHR has increased dividends consistently over the last 5 years
Dividend Yield
Current dividend yield is 1.24%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹12.35 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 3, 2022
Dividend/Share
₹1.75
Ex DateEx Date
Aug 3, 2022
Cash Dividend
Ex DateEx DateAug 17, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Aug 17, 2021
Cash Dividend
Ex DateEx DateMar 5, 2020
Dividend/Share
₹2.75
Ex DateEx Date
Mar 5, 2020
Net profit of Anuh Pharma declined 19.06% to Rs 9.51 crore in the quarter ended June 2024 as against Rs 11.75 crore during the previous quarter ended June 2023. Sales declined 14.60% to Rs 137.91 crore in the quarter ended June 2024 as against Rs 161.48 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales137.91161.48 -15 OPM %7.668.65 - PBDT14.1517.42 -19 PBT12.2715.41 -20 NP9.5111.75 -19 Powered by Capital Market - Live
Anuh Pharma standalone net profit rises 892.22% in the March 2022 quarter
Anuh Pharma standalone net profit rises 78.23% in the December 2021 quarter
Anuh Pharma Standalone September 2021 Net Sales At Rs 108.74 Crore, Down 3.11% Y-o-Y
Anuh Pharma standalone net profit rises 29.52% in the September 2021 quarter
Anuh Pharma standalone net profit declines 66.57% in the June 2021 quarter
Anuh Pharma reports standalone net profit of Rs 0.90 crore in the March 2021 quarter
Anuh Pharma standalone net profit declines 34.07% in the December 2020 quarter
Board of Anuh Pharma approves change in directorate
BRIEF-Anuh Pharma MD Bipin Shah Resigns - Investing.com India
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.16%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.15% to 0.17%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 20.79%, vs industry avg of 15.28%